Sclerosis and the Nd:YAG, Q-switched laser with multiple frequency for treatment of telangiectases, reticular veins, and residual pigmentation.
BACKGROUND
The combination of low concentrations of sclerosing solution and the Nd:YAG, Q-switched laser with multiple (quadruple) frequency provides good results in the treatment of telangiectases and reticular varicose veins of the lower extremities, as well as pigmentation that may appear during sclerotherapy.


OBJECTIVE
This paper is based on a series of patients with telangiectases and reticular veins who were treated with sclerotherapy and the Nd:YAG, Q-switched laser with quadruple frequency.


METHODS
Patients with telangiectases and reticular veins received two or three treatment sessions with polydocanol and the Nd:YAG, Q-switched laser with quadruple frequency. Then, they were assessed a clinical score corresponding to the level of improvement achieved. Residual hematic pigmentation lesions were also eliminated with the laser.


RESULTS
Excellent improvement was evident in 90% of the patients with minimal residual lesions.


CONCLUSIONS
The combined technique of sclerosing solution and the Nd:YAG laser with multiple frequency is a valid alternative for the elimination of telangiectases and reticular veins of the lower limbs. This technique has several advantages, such as the use of low concentrations of sclerosing solution, high patient acceptance levels due to minimal disturbances, and the fact that local anesthesia is unnecessary. Good results are obtained without complications and minimal residual pigmentation. These mild pigmentation can be treated with the Nd:YAG laser.
Cisneros
J L
JL
Hospital Asepeyo, Sant Cugat, Barcelona, Spain.
Del Rio
R
R
Palou
J
J
D000328:Adult; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D053685:Laser Therapy / Q000379:methods; D008297:Male; D008875:Middle Aged; D010859:Pigmentation Disorders / Q000209:etiology / Q000601:surgery / Q000628:therapy*; D012597:Sclerosing Solutions / Q000627:therapeutic use; D015911:Sclerotherapy; D013684:Telangiectasis / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D016896:Treatment Outcome; D014648:Varicose Veins / Q000473:pathology / Q000601:surgery / Q000628:therapy*
D012597:Sclerosing Solutions